Evaluating a survey tool for patient outcomes in treating methamphetamine use disorder.
Official title: Validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder: The PROMT Survey
Funded at Univ of Arkansas for Med Scis · NIH-10789055 · Data updated 2026-11-12
This study is creating a survey to help understand how people feel and what they experience while getting treatment for methamphetamine use, so we can find better ways to support their recovery beyond just stopping drug use.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | September 30, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $188,525 |
| NIH project number | 1R21DA059630-01 |
| Project ID | NIH-10789055 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with methamphetamine use disorder who are seeking treatment.
✕Less likely to help
Patients who are not diagnosed with methamphetamine use disorder or those who are not seeking treatment may not benefit from this research.
What this research studies
This research focuses on developing and validating a survey tool to assess patient-reported outcomes for individuals undergoing treatment for methamphetamine use disorder (MUD). The study aims to gather insights from patients about their experiences and improvements beyond just abstinence, which is often difficult to achieve. By incorporating patient feedback, the research seeks to inform the development of new medications and treatment strategies that better address the complexities of addiction. The findings could lead to more effective therapies and improved patient care in the future.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for methamphetamine use disorder, improving patient outcomes and quality of life.
How similar studies have gone: Previous research has shown success in utilizing patient-reported outcomes in other addiction treatments, suggesting a promising approach for this novel application.
Where this research is happening
-
Univ of Arkansas for Med Scis
Little Rock, United States Active
Researchers
- Principal investigator: Pro, George — Univ of Arkansas for Med Scis
- Study coordinator: Pro, George
Related research
Other NIH-funded projects on the same topics.
-
Calming cue-triggered cravings in methamphetamine use
Seeing if teaching people with methamphetamine use disorder a thinking-based skill (cognitive reappraisal) can reduce brain and craving reactions to drug cues.
-
Psilocybin for treatment of methamphetamine use disorder
A study is testing whether psilocybin can help people with methamphetamine use disorder feel better and stay abstinent, starting with a small, carefully monitored group.
-
Reducing Methamphetamine Use to Improve Health and Well-Being
A clinical trial tests whether giving incentives to people with methamphetamine use disorder helps them use less meth and improves heart, immune, sleep, and psychosocial health.
-
Mobilizing Recovery Resources to Improve HIV Care for People Using Methamphetamine
A patient-friendly project to help people living with HIV who use methamphetamine strengthen personal and community supports to stay engaged in care.
-
Psilocybin-assisted therapy for methamphetamine use disorder in people with HIV
A small, carefully controlled study will test whether psilocybin, given with support, can help people living with HIV who have moderate-to-severe methamphetamine use disorder.
-
Tirzepatide for Methamphetamine Use Disorder in adults with diabetes
A study will test whether an approved diabetes drug, tirzepatide, helps adults with methamphetamine use disorder who have diabetes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.